Paulo Ricardo Criado

InstitutionCentro Universitário Saúde ABC
AddressBrazil
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 2 publications in June 2020 and August 2020
    All Publications
    Bar chart showing 44 publications over 17 distinct years, with a maximum of 7 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ocampo-Candiani J, Ramos-Cavazos CJ, Arellano-Mendoza MI, Arenas-Guzmán R, Beirana-Palencia A, Salmon-Demongin A, Welsh-Hernández E, Cabo HA, Gómez-Flores M, Dominguez-Cherit J, Criado PR, Castro-López H, Alfaro-Sánchez AB, García-Vargas A, Cohen-Sabban EN, Del Solar M, Fich F, Galimberti G, Gatti CF, López-Estebaranz JL, Lupi O, Olmos-Pérez M, Pérez-Alfonzo R. International registry of dermatological manifestations secondary to COVID-19 infection in 347 Hispanic patients from 25 countries. Int J Dermatol. 2021 Aug; 60(8):956-963. PMID: 33963765.
      Citations:    Fields:    Translation:Humans
    2. Kocatürk E, Salman A, Cherrez-Ojeda I, Criado PR, Peter J, Comert-Ozer E, Abuzakouk M, Agondi RC, Al-Ahmad M, Altrichter S, Arnaout R, Arruda LK, Asero R, Bauer A, Ben-Shoshan M, Bernstein JA, Bizjak M, Boccon-Gibod I, Bonnekoh H, Bouillet L, Brzoza Z, Busse P, Campos RA, Carne E, Conlon N, Criado RF, Criado RF, de Souza Lima EM, Demir S, Dissemond J, Dogan Günaydin S, Dorofeeva I, Ensina LF, Ertas R, Ferrucci SM, Figueras-Nart I, Fomina D, Franken SM, Fukunaga A, Giménez-Arnau AM, Godse K, Gonçalo M, Gotua M, Grattan C, Guillet C, Inomata N, Jakob T, Karakaya G, Kasperska-Zajac A, Katelaris CH, Košnik M, Krasowska D, Kulthanan K, Kumaran MS, Lang C, Larco-Sousa JI, Lazaridou E, Leslie TA, Lippert U, Llosa OC, et al. The global impact of the COVID-19 pandemic on the management and course of chronic urticaria. Allergy. 2021 03; 76(3):816-830. PMID: 33284457.
      Citations: 10     Fields:    Translation:Humans
    3. Criado PR, Miot HA, Pincelli TPH, Fabro AT. From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy. Dermatol Ther. 2021 Jan; 34(1):e14565. PMID: 33219572.
      Citations: 1     Fields:    Translation:Humans
    4. Ricardo Criado P, Pincelli TPH, Criado RFJ, Abdalla BMZ, Belda Junior W. Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues. Exp Dermatol. 2020 10; 29(10):936-944. PMID: 32867008.
      Citations: 1     Fields:    Translation:Humans
    5. Criado PR, Criado PR, Criado RFJ, Criado RFJ, Pincelli TP, Yoshimoto TA, Naufal GGA, Abdalla BMZ. Chronic spontaneous urticaria exacerbation in a patient with COVID-19: rapid and excellent response to omalizumab. Int J Dermatol. 2020 Oct; 59(10):1294-1295. PMID: 32808279.
      Citations: 6     Fields:    Translation:Humans
    6. Criado PR, Pagliari C, Criado RFJ, Marques GF, Belda W. What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID-19 or asymptomatic infections due to SARS-CoV-2? Dermatol Ther. 2020 11; 33(6):e14068. PMID: 32713127.
      Citations: 8     Fields:    Translation:HumansCells
    7. Criado PR, Pagliari C, Carneiro FRO, Quaresma JAS. Lessons from dermatology about inflammatory responses in Covid-19. Rev Med Virol. 2020 09; 30(5):e2130. PMID: 32656939.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    8. Cavanagh G, Criado PR, Pagliari C, Oliveira Carneiro FR, Simões Quaresma JA, Cappel MA, Wambier C. Pernio during the COVID-19 pandemic and review of inflammation patterns and mechanisms of hypercoagulability. JAAD Case Rep. 2020 Sep; 6(9):898-899. PMID: 32875040.
      Citations: 1     
    9. Criado PR, Abdalla BMZ, de Assis IC, van Blarcum de Graaff Mello C, Caputo GC, Vieira IC. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflamm Res. 2020 Aug; 69(8):745-756. PMID: 32488318.
      Citations: 25     Fields:    Translation:HumansCellsPHPublic Health